Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma

MLA

Feng Wang, et al. “Serum MiR-182 and MiR-331-3p as Diagnostic and Prognostic Markers in Patients with Hepatocellular Carcinoma.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 36, no. 10, Oct. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5cb53fc0cf563387f19d8317e02594ac&authtype=sso&custid=ns315887.

APA

Feng Wang, Yali Cao, Jianguo Shao, Lin Chen, & Feihu Chu. (2014). Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 36(10).

Chicago

Feng Wang, Yali Cao, Jianguo Shao, Lin Chen, and Feihu Chu. 2014. “Serum MiR-182 and MiR-331-3p as Diagnostic and Prognostic Markers in Patients with Hepatocellular Carcinoma.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 36 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5cb53fc0cf563387f19d8317e02594ac&authtype=sso&custid=ns315887.